- Home
- LFMD vs FENC Comparison
LFMD vs FENC Comparison
Compare LFMD & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFMD | FENC |
|---|---|---|
| Founded | 1994 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.5M | 276.3M |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | LFMD | FENC |
|---|---|---|
| Price | $3.77 | $7.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $10.22 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.3M | 179.1K |
| Earning Date | 03-09-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $250,091,814.00 | $38,790,000.00 |
| Revenue This Year | $13.65 | N/A |
| Revenue Next Year | N/A | $70.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 28.78 | N/A |
| 52 Week Low | $3.18 | $4.68 |
| 52 Week High | $15.84 | $9.92 |
Technical Indicators
Market Signals| Indicator | LFMD | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 48.79 | 48.02 |
| Support Level | $3.84 | $7.35 |
| Resistance Level | $4.36 | $7.82 |
| Average True Range (ATR) | 0.25 | 0.39 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 42.21 | 31.06 |
Price Performance
Historical ComparisonAbout LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.